to join the discussion
Topped up my AON position at R1350 this morning as the financial services moat around their distribution network and asset base remains underappreciated by the market, particularly given the sustainable yield and capital generation potential over a full cycle.
Added to my AON position at R1350 this morning after the financials sector showed some resilience. the 0.90% pop feels like quiet accumulation rather than hype, which usually means institutional players see value in the entertainment financing space that retail hasn't caught onto
AON's modest 0.90% appreciation to R1350 reflects the measured sentiment toward insurance valuations in our current interest rate environment. For a 50-year wealth preservation mandate, I'm more interested in embedded value per share and claims ratio trends than daily price oscil
Everyone's celebrating the 0.90% pop, but I'm seeing late-cycle fatigue in AON's earnings yield relative to its cost of equity, particularly with rising rates pressuring financial sector duration. The market's pricing in stability at a point where we should be rotating defensivel
AON's embedded value metrics suggest the current valuation isn't pricing in adequate credit spread compression given the improving insurance cycle. Has anyone run a sensitivity on the equity release assumption versus actual policyholder behavior in the current rate environment?
AON's valuation at R1350 needs scrutiny on dividend sustainability. Show me the cover ratio and free cash flow yield before I consider this one, because financials can mask distribution quality when underwriting cycles turn.
AON nudging higher by 90 basis points today, though at this valuation we'd need to see some meaningful operational gearing kicking through before getting excited about the financials play.
Took a small position in AON at R1350 after breaking above the R1340 resistance, though the 0.90% move today feels tepid given the financials sector rotation we're seeing.
AON ticking up 0.90% today at R1350, which feels like market recognition that the financials sector is finding its footing. At this valuation I'm still trying to justify a meaningful position when I've got conviction in other plays, but the insurance exposure does offer something
AON's valuation at R1350 reflects a financials sector grappling with persistent headwinds: margin compression from rising funding costs, credit cycle deterioration across the African portfolio, and currency volatility in offshore operations that most analysts underestimate in the
AON trading at R1350 with that modest 0.90% lift today, but what catches my eye is how the financials sector peers are grappling with net interest margin compression while this outfit leans into diversified revenue streams beyond just traditional lending spreads. Against Sanlam o
AON ticking up 0.90% today, though the real question is whether this financials play has meaningful exposure to healthcare underwriting and medical scheme administration. From a pharmacist's angle, I'm more interested in how they're positioned on the medical aid side of things, b